A possible link between multiple sclerosis and Creutzfeldt-Jakob disease based on clinical, genetic, pathological and

Alan Ebringer1, Taha Rashid, Clyde Wilson

  • 1Infection and Immunity Group, Division of Health and Life Sciences, King's College London, 150 Stamford Street, London SE1 9NN, UK. alan.ebringer@kcl.ac.uk

Medical Hypotheses
|December 25, 2004
PubMed

Insights

Multiple sclerosis and sporadic Creutzfeldt-Jakob disease may share a common microbial trigger, possibly Acinetobacter. Further immunological studies are needed to investigate this potential link in patients.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Neurology

Background:

  • Multiple sclerosis (MS) is an immune-mediated demyelinating disease.
  • Environmental (microbial) agents are increasingly implicated in MS etiology.
  • Sporadic Creutzfeldt-Jakob disease (sCJD) shares clinical and pathological similarities with severe MS.

Purpose of the Study:

  • To explore the hypothesis that MS and sCJD share a common aetiopathogenic factor.
  • To investigate the potential role of Acinetobacter microbes in the pathogenesis of both diseases.

Main Methods:

  • Comparative analysis of clinical, genetic, pathological, and immunological features of MS and sCJD.
  • Proposal for future immunological studies in large patient cohorts.

Main Results:

  • Identified significant similarities between MS and sCJD, including rapid disease progression and fatality.
  • Highlighted the potential for a shared underlying cause, such as microbial infection.

Conclusions:

  • The observed similarities suggest a possible common aetiopathogenic factor, potentially Acinetobacter infection, in MS and sCJD.
  • Further immunological investigation is warranted to validate this hypothesis and understand the link between these neurological diseases.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...